740 Y-P TFA
Based on 261 publication(s) in Google Scholar
740 Y-P TFA is a potent and cell-permeable PI3K activator. 740 Y-P TFA readily binds GST fusion proteins containing both the N- and C- terminal SH2 domains of p85 but fails to bind GST alone.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C141H222N43O39PS3.xC2HF3O2
- Masse moléculaire:3270.70 (free acid)
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) 740 Y-P TFA
More- Mol Cancer. 2022 May 10;21(1):112. [Abstract]
- Drug Resist Updat. 2024 Dec 3:78:101179. [Abstract]
- Nat Commun. 2024 Sep 12;15(1):7996. [Abstract]
- Exp Mol Med. 2023 May;55(5):939-951. [Abstract]
- Mol Cell. 2025 Mar 19:S1097-2765(25)00186-8. [Abstract]
- Theranostics. 2024 Jul 8;14(11):4278-4296. [Abstract]
- Genes Dis. 2021 Jul 1;9(6):1650-1661. [Abstract]
- J Clin Invest. 2023 Jan 17;133(2):e153470. [Abstract]
- J Exp Clin Cancer Res. 2021 Aug 12;40(1):255. [Abstract]
- J Exp Clin Cancer Res. 2020 Jun 30;39(1):123. [Abstract]
- Adv Sci (Weinh). 2026 Jan 21:e19191. [Abstract]
- Adv Sci (Weinh). 2025 Apr;12(13):e2410032. [Abstract]
- Biomaterials. 2019 Feb;194:57-72. [Abstract]
- Carbon. 2023 Jan 25, 217, 118617.
- J Control Release. 2025 Oct 22;388(Pt 2):114350. [Abstract]
- Cell Death Dis. 2025 Jun 16;16(1):451. [Abstract]
- Cell Death Dis. 2021 Sep 13;12(9):845. [Abstract]
- Int J Biol Sci. 2025 Aug 11;21(12):5206-5222. [Abstract]
- Cell Commun Signal. 2020 Aug 24;18(1):131. [Abstract]
- Phytomedicine. 2026 Jul:156:158218. [Abstract]
- Phytomedicine. 2026 Apr:153:158000. [Abstract]
- Phytomedicine. 2025 May:140:156498. [Abstract]
- Phytomedicine. 2023 Dec:121:155117. [Abstract]
- Phytomedicine. 2023 Jul 25:116:154873. [Abstract]
- Phytomedicine. 2022 Oct:105:154360. [Abstract]
- Phytomedicine. 2022 May:99:154014. [Abstract]
- Mater Today Bio. 2022 Jul 1;16:100344. [Abstract]
- Genome Med. 2025 Sep 25;17(1):102. [Abstract]
- Acta Biomater. 2018 Nov:81:278-292. [Abstract]
- J Transl Med. 2024 Nov 29;22(1):1085. [Abstract]
- J Transl Med. 2023 Nov 16;21(1):817. [Abstract]
- J Transl Med. 2021 Feb 10;19(1):62. [Abstract]
- J Colloid Interface Sci. 2025 Oct 8;703(Pt 2):139206. [Abstract]
- Proc Natl Acad Sci U S A. 2026 Jul 7;123(27):e2523789123.
- Apoptosis. 2025 Feb;30(1-2):16-34. [Abstract]
- Apoptosis. 2024 Aug;29(7-8):1185-1197. [Abstract]
- Int J Biol Macromol. 2025 Jan 10:139766. [Abstract]
- Int J Biol Macromol. 2024 Sep 10:135547. [Abstract]
- Int J Biol Macromol. 2023 Jul 31:244:125373. [Abstract]
- BMC Med. 2022 Dec 8;20(1):475. [Abstract]
- J Headache Pain. 2022 Aug 10;23(1):98. [Abstract]
- Int J Mol Med. 2025 Nov;56(5):194. [Abstract]
- Int J Mol Med. 2023 May;51(5):40. [Abstract]
- Int J Mol Med. 2021 May;47(5):67. [Abstract]
- Int J Mol Med. 2021 Feb;47(2):688-698. [Abstract]
- Mol Med. 2023 Oct 3;29(1):133. [Abstract]
- Arch Pharm Res. 2021 Feb;44(2):194-204. [Abstract]
- Phytother Res. 2024 Jul;38(7):3509-3524. [Abstract]
- Phytother Res. 2023 Aug;37(8):3572-3582. [Abstract]
- Free Radic Biol Med. 2023 Oct 10;209(Pt 1):55-69. [Abstract]
- World J Gastroenterol. 2026 Mar 28;32(12).
- Cell Rep. 2021 Nov 16;37(7):110007. [Abstract]
- Cell Prolif. 2022 Sep 26;e13342. [Abstract]
- Chin Med. 2022 Sep 29;17(1):115. [Abstract]
- Int J Oncol. 2021 Jul;59(1):42. [Abstract]
- Int J Oncol. 2021 May;58(5):23. [Abstract]
- J Invest Dermatol. 2026 Jan 23:S0022-202X(26)00030-8. [Abstract]
- PLoS Biol. 2026 Jan 22;24(1):e3003581. [Abstract]
- J Ethnopharmacol. 2025 Jan 18:119381. [Abstract]
- J Ethnopharmacol. 2025 Jan 30;337(Pt 2):118910. [Abstract]
- J Ethnopharmacol. 2024 May 10:325:117768. [Abstract]
- J Ethnopharmacol. 2024 Mar 25:322:117628. [Abstract]
- J Ethnopharmacol. 2021 Dec 5:281:114438. [Abstract]
- Biomater Adv. 2026 Mar:180:214576. [Abstract]
- J Agric Food Chem. 2025 May 2. [Abstract]
- J Agric Food Chem. 2022 Dec 21;70(50):15804-15817. [Abstract]
- Ecotoxicol Environ Saf. 2026 Mar 15:313:119962. [Abstract]
- Biochem Pharmacol. 2025 Dec;242(Pt 3):117405. [Abstract]
- Biochem Pharmacol. 2024 Nov 9:116620. [Abstract]
- Cell Mol Life Sci. 2024 Mar 13;81(1):133. [Abstract]
- Cell Biosci. 2019 Aug 27;9:68. [Abstract]
- Life Sci. 2021 Nov 1:284:119107. [Abstract]
- Life Sci. 2019 Sep 15:233:116696. [Abstract]
- Bioresour Bioprocess. 2025 Jul 30;12(1):82. [Abstract]
- Mol Cell Proteomics. 2023 Sep;22(9):100628. [Abstract]
- Inflammopharmacology. 2023 Feb;31(1):369-384. [Abstract]
- Drug Des Devel Ther. 2026 Jan 27:20:561725. [Abstract]
- Drug Des Devel Ther. 2026 Jan 27;20:1-16.
- Cells. 2023 Jan 3;12(1):194. [Abstract]
- Pharm Biol. 2022 Dec;60(1):75-86. [Abstract]
- Gene Ther. 2024 Nov;31(11-12):594-606. [Abstract]
- Eur J Pharmacol. 2026 May 28:1025:178925. [Abstract]
- Pharmaceuticals (Basel). 2025 Sep 16;18(9):1378. [Abstract]
- Cell Biol Toxicol. 2025 Jul 1;41(1):110. [Abstract]
- Eur J Pharmacol. 2024 Sep 10:176824. [Abstract]
- Eur J Pharmacol. 2024 Sep 10:176991. [Abstract]
- Eur J Pharmacol. 2024 Apr 5:968:176401. [Abstract]
- Eur J Pharmacol. 2023 Sep 5:954:175863. [Abstract]
- Int Immunopharmacol. 2026 Mar 15:173:116306. [Abstract]
- Int Immunopharmacol. 2025 Aug 3:163:115304. [Abstract]
- Int Immunopharmacol. 2025 Apr 4:151:114352. [Abstract]
- Int J Mol Sci. 2024 Dec 25;26(1):84. [Abstract]
- Noncoding RNA Res. 2024 Nov 12:11:38-47. [Abstract]
- Int Immunopharmacol. 2024 Jul 26:139:112717. [Abstract]
- Int Immunopharmacol. 2024 May 17:134:112241. [Abstract]
- Int Immunopharmacol. 2024 May 30:133:112005. [Abstract]
- Int Immunopharmacol. 2023 Sep 5;124(Pt A):110876. [Abstract]
- Int Immunopharmacol. 2023 Sep:122:110579. [Abstract]
- Int J Mol Sci. 2023 May 19;24(10):9000. [Abstract]
- Bone Joint Res. 2025 Feb 6;14(2):97-110. [Abstract]
- Mol Neurobiol. 2025 Mar;62(3):3615-3629. [Abstract]
- Glia. 2023 Mar;71(3):720-741. [Abstract]
- Front Pharmacol. 2021 Jul 15:12:667644. [Abstract]
- Front Pharmacol. 2020 Feb 25;11:114. [Abstract]
- J Integr Med. 2025 Sep 4:S2095-4964(25)00137-2. [Abstract]
- J Nutr Biochem. 2024 Jul 16:109702. [Abstract]
- ACS Omega. 2022 Nov 16;7(47):42723-42732. [Abstract]
- J Nutr Biochem. 2022 Feb:100:108882. [Abstract]
- Bioorg Chem. 2025 Dec 18:169:109400. [Abstract]
- Bioorg Chem. 2025 Sep 16:165:109002. [Abstract]
- Mol Med Rep. 2026 Feb;33(2):60. [Abstract]
- Mol Med Rep. 2021 Jan;23(1):76. [Abstract]
- Stem Cell Rev Rep. 2026 Aug;22(6):2919-2937. [Abstract]
- Sci Rep. 2026 Jun 26. [Abstract]
- Mediators Inflamm. 2026;2026(1):e3260549. [Abstract]
- Stem Cell Rev Rep. 2026 Jan 30;22(3):1325-1340.
- Sci Rep. 2025 May 9;15(1):16205. [Abstract]
- Sci Rep. 2025 Apr 19;15(1):13539. [Abstract]
- Sci Rep. 2025 Mar 4;15(1):7639. [Abstract]
- Sci Rep. 2025 Mar 20;15(1):9644. [Abstract]
- Sci Rep. 2024 Aug 30;14(1):20231. [Abstract]
- Sci Rep. 2024 Sep 5;14(1):20802. [Abstract]
- Sci Rep. 2023 Jul 21;13(1):11795. [Abstract]
- Sci Rep. 2021 Sep 29;11(1):19268. [Abstract]
- Eur J Med Res. 2025 Dec 30;31(1):170. [Abstract]
- Cancers (Basel). 2025 Aug 29;17(17):2846. [Abstract]
- Cancers (Basel). 2023 Mar 28;15(7):2023. [Abstract]
- Cell Signal. 2026 Sep:145:112570. [Abstract]
- Cell Signal. 2026 Sep:145:112616. [Abstract]
- Cell Signal. 2025 Dec 18:139:112336. [Abstract]
- Neuropharmacology. 2025 Nov 15:279:110631. [Abstract]
- Cell Signal. 2025 Nov:135:111984. [Abstract]
- Cell Signal. 2025 Nov:135:112026. [Abstract]
- J Cell Mol Med. 2024 Jul;28(13):e18386. [Abstract]
- Oncol Rep. 2022 Oct;48(4):169. [Abstract]
- Mol Cell Biochem. 2022 Jul;477(7):1947-1957. [Abstract]
- J Dairy Sci. 2022 Apr;105(4):3405-3415. [Abstract]
- Mol Cell Biochem. 2022 May;477(5):1541-1553. [Abstract]
- Oncol Rep. 2021 May;45(5):63. [Abstract]
- Cell Signal. 2020 Jul;71:109606. [Abstract]
- Oncol Rep. 2020 Mar;43(3):919-929. [Abstract]
- J Inflamm Res. 2026 Apr 17:19:592917. [Abstract]
- J Inflamm Res. 2025 Aug 3:18:10389-10402. [Abstract]
- Ann N Y Acad Sci. 2025 Nov 24. [Abstract]
- iScience. 2024 Jan 17;27(2):108926. [Abstract]
- Comp Biochem Physiol C Toxicol Pharmacol. 2026 Jun 4:110596. [Abstract]
- BMC Complement Med Ther. 2023 Aug 22;23(1):295. [Abstract]
- Drug Dev Res. 2022 Nov;83(7):1673-1682. [Abstract]
- Drug Dev Res. 2022 Aug;83(5):1152-1166. [Abstract]
- Fish Shellfish Immunol. 2022 Jan:120:648-657. [Abstract]
- Front Biosci (Landmark Ed). 2024 Aug 19;29(8):289. [Abstract]
- BMC Cancer. 2023 Jul 5;23(1):628. [Abstract]
- BMC Cancer. 2022 Jun 18;22(1):671. [Abstract]
- OncoTargets and Therapy Dovepress. 2019 Oct 16;12:8537-8552. [Abstract]
- Naunyn Schmiedebergs Arch Pharmacol. 2026 Jun;399(9):14421-14437. [Abstract]
- Funct Integr Genomics. 2026 Jan 27;26(1):32. [Abstract]
- J Cell Physiol. 2024 Jun;239(6):e31259. [Abstract]
- Naunyn Schmiedebergs Arch Pharmacol. 2024 Feb;397(2):1003-1013. [Abstract]
- J Funct Foods. 2023 Oct, 109, 105770.
- J Hepatocell Carcinoma. 2021 Nov 3;8:1323-1338. [Abstract]
- Viruses. 2023 Jul 28;15(8):1646. [Abstract]
- J Bioenerg Biomembr. 2026 Feb 12;58(1):2. [Abstract]
- Mol Immunol. 2025 Dec 18:189:181-191. [Abstract]
- Mol Immunol. 2025 Sep:185:27-38. [Abstract]
- Epigenetics. 2023 Dec;18(1):2239607. [Abstract]
- Pathol Res Pract. 2023 Sep:249:154717. [Abstract]
- J Pharm Pharmacol. 2022 Sep 1;74(9):1251-1260. [Abstract]
- Toxicol Appl Pharmacol. 2026 Jun 26:514:117928. [Abstract]
- J Biochem Mol Toxicol. 2025 Apr;39(4):e70210. [Abstract]
- Genomics. 2023 Jul;115(4):110636. [Abstract]
- Toxicol Appl Pharmacol. 2022 Apr 15:441:115971. [Abstract]
- Cytokine. 2022 Feb:150:155776. [Abstract]
- Toxicol Appl Pharmacol. 2020 Dec 15;409:115335. [Abstract]
- Immun Inflamm Dis. 2026 Apr;14(4):e70429. [Abstract]
- Appl Biochem Biotechnol. 2026 Apr 28. [Abstract]
- Appl Biochem Biotechnol. 2026 Mar 13. [Abstract]
- Exp Cell Res. 2026 Apr 1;457(1):114924. [Abstract]
- Int J Biochem Cell Biol. 2026 May:194:106928. [Abstract]
- J Gastroenterol Hepatol. 2025 Aug;40(8):1991-2006. [Abstract]
- Arch Biochem Biophys. 2023 Jul 15:743:109645. [Abstract]
- Cancer Med. 2023 Mar;12(5):5781-5797. [Abstract]
- Exp Cell Res. 2019 Dec 15;385(2):111691. [Abstract]
- Electron J Biotechnol. 2025 Aug 13.
- Food Chem Toxicol. 2025 Oct:204:115664. [Abstract]
- Biol Reprod. 2023 Nov 15;109(5):736-748. [Abstract]
- Mol Biol Rep. 2023 Jan;50(1):687-696. [Abstract]
- Kaohsiung J Med Sci. 2025 Nov 5:e70131. [Abstract]
- J Steroid Biochem Mol Biol. 2025 Jul 3:254:106825. [Abstract]
- Oral Dis. 2024 Oct;30(7):4231-4242. [Abstract]
- Genes (Basel). 2023 Apr 20;14(4):944. [Abstract]
- Exp Eye Res. 2023 Jan:226:109335. [Abstract]
- Cell Biochem Biophys. 2025 Jun;83(2):2023-2033. [Abstract]
- Cell Biochem Biophys. 2025 Jun;83(2):1785-1798. [Abstract]
- Neurogastroenterol Motil. 2020 Oct;32(10):1514-1528. [Abstract]
- Theriogenology. 2026 Aug:260:117909. [Abstract]
- IBRO Neurosci Rep. 2026 Jan 21:20:186-195. [Abstract]
- Hum Cell. 2026 Apr 7;39(4):61. [Abstract]
- Discov Oncol. 2025 Sep 30;16(1):1789. [Abstract]
- Curr Microbiol. 2025 Feb 3;82(3):110. [Abstract]
- PLoS One. 2024 Sep 27;19(9):e0311143. [Abstract]
- PLoS One. 2024 Oct 16;19(10):e0311419. [Abstract]
- World J Gastrointest Oncol. 2023 Oct 15;15(10):1739-1755. [Abstract]
- Toxicol In Vitro. 2022 Apr;80:105328. [Abstract]
- Technol Cancer Res Treat. 2020 Jan-Dec:19:1533033820957023. [Abstract]
- J Mol Histol. 2023 Dec;54(6):621-631. [Abstract]
- Clin Med Insights Oncol. 2021 May 5:15:11795549211012666. [Abstract]
- Biochem Biophys Res Commun. 2025 Sep 8:778:152337. [Abstract]
- Biochem Biophys Res Commun. 2025 May 16:771:152037. [Abstract]
- Cancer Rep (Hoboken). 2025 May;8(5):e70220. [Abstract]
- Arch Dermatol Res. 2024 Dec 5;317(1):70. [Abstract]
- Biochem Biophys Res Commun. 2024 Jul 23:718:149983. [Abstract]
- Biochem Biophys Res Commun. 2023 Sep 3:671:246-254. [Abstract]
- J Clin Lab Anal. 2022 Dec;36(12):e24720. [Abstract]
- Korean J Physiol Pharmacol. 2022 Nov 1;26(6):541-556. [Abstract]
- Biochem Biophys Res Commun. 2022 May 21;605:162-170. [Abstract]
- Onco Targets Ther. 2019 Dec 4;12:10639-10650. [Abstract]
- Int J Gen Med. 2025 Sep 19:18:5699-5716. [Abstract]
- Mol Genet Genomics. 2026 Jun 16;301(1):138. [Abstract]
- Cytotechnology. 2026 Jun;78(3):96. [Abstract]
- Cytotechnology. 2025 Apr;77(2):77. [Abstract]
- Exp Ther Med. 2021 Sep;22(3):1017. [Abstract]
- Oncol Lett. 2023 Nov 15;27(1):17. [Abstract]
- Oncol Lett. 2023 Apr 13;25(6):224. [Abstract]
- Oncol Lett. 2021 Dec;22(6):812. [Abstract]
- Curr Med Sci. 2025 Oct 16. [Abstract]
- Curr Med Sci. 2025 Apr;45(2):253-263. [Abstract]
- In Vitro Cell Dev Biol Anim. 2022 Jun;58(6):491-502. [Abstract]
- Ir J Med Sci. 2023 Apr;192(2):561-567. [Abstract]
- Eur J Histochem. 2025 Jun 17;69(3). [Abstract]
- Braz J Med Biol Res. 2025 Mar 24:58:e14408. [Abstract]
- Braz J Med Biol Res. 2024 Aug 19:57:e13796. [Abstract]
- Respir Physiol Neurobiol. 2020 Oct;281:103496. [Abstract]
- Am J Transl Res. 2025 Mar 15;17(3):2145-2153. [Abstract]
- Am J Transl Res. 2021 Apr 15;13(4):2060-2076. [Abstract]
- Curr Eye Res. 2025 Jun 24:1-9. [Abstract]
- Lett Drug Des Discov. 2026 Jan 16.
- Folia Neuropathol. 2025;63(3):269-281. [Abstract]
- Tradit Med Res. 2020 May.
- bioRxiv. 2026 Apr 1:2026.03.31.715684. [Abstract]
- bioRxiv. 2026 Mar 29:2026.03.27.714536. [Abstract]
- SSRN. 2025 Dec 12.
- SSRN. 2025 Sep 19.
- bioRxiv. 2025 Mar 26:2025.03.24.645017. [Abstract]
- Biomed Pharmacother. 2024 Nov:180:117560. [Abstract]
- Heliyon. 2024 Aug 20;10(17):e36579. [Abstract]
- Heliyon. 2024 Jul 10;10(14):e34397. [Abstract]
- Heliyon. 2024 Jun 10;10(12):e32802. [Abstract]
- Heliyon. 2024 May 31;10(11):e32230. [Abstract]
- Research Square Preprint. 2024 May 2.
- Research Square Preprint. 2024 Mar 25.
- Research Square Preprint. 2023 Aug 10.
- Research Square Preprint. 2023 Apr 13.
- bioRxiv. 2023 Mar 25:2023.03.23.534007. [Abstract]
- Contrast Media Mol Imaging. 2022 Jul 14:2022:2109908. [Abstract]
- Bioengineered. 2022 Apr;13(4):10047-10060. [Abstract]
- Research Square Print. 2022 May.
- Bioengineered. 2021 Dec;12(2):12940-12953. [Abstract]
- Aging (Albany NY). 2021 Sep 27;13(18):22502-22515. [Abstract]
- Dis Markers. 2021 Sep 1:2021:9950663. [Abstract]
- Oxid Med Cell Longev. 2021 Mar 30:2021:6661534. [Abstract]
- Biomed Pharmacother. 2020 Nov;131:110689. [Abstract]
-
WB
-
WB
-
WB
-
WB
-
WB
Activité biologique
740 Y-P TFA (50 μg/ml; 48 hours) specificly stimulates mitogenesis in medium is better than EGF or FGF at stimulating entry into S-phase, it shows the percentage of cells in S-phase for 48.3% in C2 cells. Additionally, LY294002 or wortmannin potently inhibits the mitogenic response stimulated by the 740 Y-P TFA peptide[1].740 Y-P TFA (1 μg/mL) stimulates mitogenesis at the lowest concentration tested. The peptide stimulates mitogenesis in both the presence and absence of serum (0.5%), and in the former instance a maximal response observed at 50 μg/mL. 740Y-P to stimulate mitogenesis is highly specific and not a general feature of a cell permeable SH2 domain binding peptides[1].740 Y-P TFA (30 μM; 24 hours) remarkably inhibits the level of LC3-II/LC3-I in GO-induced PC12 cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:PC12 cells
-
Concentration:30 μM
-
Incubation Time:24 hours
-
Result:Inhibited the protein expression of LC3-II.
Chemical Information
-
Masse moléculaire 3270.70 (free acid)
-
Formule C141H222N43O39PS3.xC2HF3O2
-
Synonyms
740YPDGFR TFA; PDGFR 740Y-P TFA
-
Sequence
Arg-Gln-Ile-Lys-Ile-Trp-Phe-Gln-Asn-Arg-Arg-Met-Lys-Trp-Lys-Lys-Ser-Asp-Gly-Gly-{Tyr(PO2)}-Met-Asp-Met-Ser
-
Sequence Shortening
RQIKIWFQNRRMKWKKSDGG-{PO2Y}-MDMS
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (261)
-
Journal Impact Factor
-
Most Recent
-
Mol Cancer
Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer. [Abstract]2022 May 10;21(1):112. PMID: 35538494 -
Drug Resist Updat
CEA-induced PI3K/AKT pathway activation through the binding of CEA to KRT1 contributes to oxaliplatin resistance in gastric cancer. [Abstract]2024 Dec 3:78:101179. PMID: 39644827 -
Nat Commun
Engineered model of heart tissue repair for exploring fibrotic processes and therapeutic interventions. [Abstract]2024 Sep 12;15(1):7996. PMID: 39266508 -
Exp Mol Med
Mesenchymal stem cell-derived extracellular vesicles protect against abdominal aortic aneurysm formation by inhibiting NET-induced ferroptosis. [Abstract]2023 May;55(5):939-951. PMID: 37121969
740 Y-P TFA purchased from MedChemExpress. Usage Cited in: Exp Mol Med. 2023 May;55(5):939-951. [Abstract]
Western blot showing PI3K, AKT, p-AKT, GPX4, ACSL4, TFR1, and SLC7A11 in the tissue samples of ApoE−/− mice infused with saline or Ang II, with or without 740 Y-P (10 mg/kg/d) treatment. n = 3 in each group.
-
Mol Cell
PI3Kβ functions as a protein kinase to promote cellular protein O-GlcNAcylation and acetyl-CoA production for tumor growth. [Abstract]2025 Mar 19:S1097-2765(25)00186-8. PMID: 40132583 -
Theranostics
Stimulation by exosomes from hypoxia-preconditioned hair follicle mesenchymal stem cells facilitates mitophagy by inhibiting the PI3K/AKT/mTOR signaling pathway to alleviate ulcerative colitis. [Abstract]2024 Jul 8;14(11):4278-4296. PMID: 39113800
740 Y-P TFA purchased from MedChemExpress. Usage Cited in: Theranostics. 2024 Jul 8;14(11):4278-4296. [Abstract]
Western blotting was used to measure p-PI3K/PI3K, p-AKT/AKT, and p-mTOR/mTOR expression in MODE-K cells incubated with 740 Y-P (25 μg/mL; 24 h).
-
Genes Dis
PGRN exacerbates the progression of non-small cell lung cancer via PI3K/AKT/Bcl-2 antiapoptotic signaling. [Abstract]2021 Jul 1;9(6):1650-1661. PMID: 36157487 -
J Clin Invest
Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47. [Abstract]2023 Jan 17;133(2):e153470. PMID: 36413402 -
J Exp Clin Cancer Res
XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor. [Abstract]2021 Aug 12;40(1):255. PMID: 34384466 -
J Exp Clin Cancer Res
BDH2 triggers ROS-induced cell death and autophagy by promoting Nrf2 ubiquitination in gastric cancer. [Abstract]2020 Jun 30;39(1):123. PMID: 32605589
740 Y-P TFA purchased from MedChemExpress. Usage Cited in: J Exp Clin Cancer Res. 2020 Jun 30;39(1):123. [Abstract]
Protein expression levels of p-AktSer473, p-mTORSer2448 with or without 740Y-P treatment are measured by Western blotting. Pretreatment with 740Y-P (PI3K agonist) inhibits downregulation of p-AktSer473 and p-mTORSer2448 expression induced by overexpression of BDH2.
-
Adv Sci (Weinh)
Macrophage-Derived Ferritin Exacerbates Silica-Induced Pulmonary Fibrosis via PIK3R2-Mediated Fibroblast Differentiation. [Abstract]2026 Jan 21:e19191. PMID: 41566645 -
Adv Sci (Weinh)
Intestinal Gastrin/CCKBR Axis Protects against Type 2 Diabetes by Reducing Intestinal Glucose Absorption through the PI3K/Akt/eIF4B Signaling Pathway. [Abstract]2025 Apr;12(13):e2410032. PMID: 39950948
740 Y-P TFA purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Apr;12(13):e2410032. [Abstract]
Protein expression and quantification of SGLT1, GLUT2, p-PI3K, p-AKT, p-S6K1, and p-eIF4B were performed. GAPDH was used to normalize the data. 740Y-P (30 μM; 24 h) was an activator of the PI3K/Akt signaling pathway.
-
Biomaterials
Mussel-inspired injectable hydrogel and its counterpart for actuating proliferation and neuronal differentiation of retinal progenitor cells. [Abstract]2019 Feb;194:57-72. PMID: 30583149 -
-
J Control Release
Inflammation-targeted nanoparticles modulate macrophage polarization for coronary therapy in Kawasaki disease. [Abstract]2025 Oct 22;388(Pt 2):114350. PMID: 41135700 -
Cell Death Dis
SIRPα blockade therapy potentiates immunotherapy by inhibiting PD-L1+ myeloid cells in hepatocellular carcinoma. [Abstract]2025 Jun 16;16(1):451. PMID: 40523887 -
Cell Death Dis
LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma. [Abstract]2021 Sep 13;12(9):845. PMID: 34518524 -
Int J Biol Sci
ANXA6 Overexpression Causes Abnormal Decidual Macrophage-Trophoblast Crosstalk in Recurrent Spontaneous Abortion. [Abstract]2025 Aug 11;21(12):5206-5222. PMID: 40959268 -
Cell Commun Signal
Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma. [Abstract]2020 Aug 24;18(1):131. PMID: 32831114 -
Phytomedicine
Narciclasine alleviates zearalenone-induced focal adhesion damage and anoikis in rat Sertoli cells through PI3K signaling pathway. [Abstract]2026 Jul:156:158218. PMID: 42025009 -
Phytomedicine
Platycodin D alleviates idiopathic pulmonary fibrosis by targeting PPP2R1A and regulating the PP2A-mediated PI3K/Akt pathway to inhibit fibroblast transdifferentiation. [Abstract]2026 Apr:153:158000. PMID: 41759424 -
Phytomedicine
Artesunate attenuates skin hypertrophic scar formation by inhibiting fibroblast activation and EndMT of vascular endothelial cells. [Abstract]2025 May:140:156498. PMID: 40055124 -
Phytomedicine
Isovitexin alleviates hepatic fibrosis by regulating miR-21-mediated PI3K/Akt signaling and glutathione metabolic pathway: based on transcriptomics and metabolomics. [Abstract]2023 Dec:121:155117. PMID: 37820467 -
Phytomedicine
2023 Jul 25:116:154873. PMID: 37257328 -
Phytomedicine
A discovery of clinically approved Panlongqi Tablet for repositioning to treat osteoarthritis by inhibiting PI3K/AKT activation. [Abstract]2022 Oct:105:154360. PMID: 35964457 -
Phytomedicine
Biosynthesis and cytotoxic effect of silymarin-functionalized selenium nanoparticles induced autophagy mediated cellular apoptosis via downregulation of PI3K/Akt/mTOR pathway in gastric cancer. [Abstract]2022 May:99:154014. PMID: 35247670 -
Mater Today Bio
Carbon dots enhance extracellular matrix secretion for dentin-pulp complex regeneration through PI3K/Akt/mTOR pathway-mediated activation of autophagy. [Abstract]2022 Jul 1;16:100344. PMID: 35833197 -
Genome Med
2025 Sep 25;17(1):102. PMID: 40999499 -
Acta Biomater
Graphene oxide induces p62/SQSTM-dependent apoptosis through the impairment of autophagic flux and lysosomal dysfunction in PC12 cells. [Abstract]2018 Nov:81:278-292. PMID: 30273743
740 Y-P TFA purchased from MedChemExpress. Usage Cited in: Acta Biomater. 2018 Nov:81:278-292. [Abstract]
PC12 cells are pretreated with 740-YP (30 μM), or SC79 (13.7 μM), or 3BDO (100 μM) for 1 h, and for the duration of GO (50 μg/mL) incubation for 24 h. LC3 turnover is detected by western blotting.
-
J Transl Med
Cholesterol overload in macrophages drives metabolic dysfunction-associated steatohepatitis via inhibiting 7-dehydrocholesterol reductase in mice. [Abstract]2024 Nov 29;22(1):1085. PMID: 39614331 -
J Transl Med
HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K/AKT signaling pathway in human anaplastic thyroid carcinoma. [Abstract]2023 Nov 16;21(1):817. PMID: 37974228 -
J Transl Med
Rosuvastatin exerts anti-atherosclerotic effects by improving macrophage-related foam cell formation and polarization conversion via mediating autophagic activities. [Abstract]2021 Feb 10;19(1):62. PMID: 33568202 -
J Colloid Interface Sci
Engineering a cancer organoid-based platform for the early preclinical evaluation of the antitumor efficacy and safety of hydrophilic 2D metallic MoS2 nanosheets. [Abstract]2025 Oct 8;703(Pt 2):139206. PMID: 41082801 -
-
Apoptosis
PRELP inhibits colorectal cancer progression by suppressing epithelial-mesenchymal transition and angiogenesis via the inactivation of the FGF1/PI3K/AKT pathway. [Abstract]2025 Feb;30(1-2):16-34. PMID: 39242474 -
Apoptosis
TBC1D10B promotes tumor progression in colon cancer via PAK4‑mediated promotion of the PI3K/AKT/mTOR pathway. [Abstract]2024 Aug;29(7-8):1185-1197. PMID: 38824479 -
Int J Biol Macromol
Sibanin, a novel black fly-derived Kunitz protease inhibitor, prevents thrombus formation in mice by anticoagulation-antiplatelet duality. [Abstract]2025 Jan 10:139766. PMID: 39800030 -
Int J Biol Macromol
Polysaccharides from Ostrea rivularis alleviate type II diabetes induced-retinopathy and VGEF165-induced angiogenesis via PI3K/AKT signaling pathway. [Abstract]2024 Sep 10:135547. PMID: 39265902 -
Int J Biol Macromol
Polysaccharide from Strongylocentrotus nudus eggs regulates intestinal epithelial autophagy through CD36/PI3K-Akt pathway to ameliorate inflammatory bowel disease. [Abstract]2023 Jul 31:244:125373. PMID: 37327932 -
BMC Med
A novel 450-nm laser-mediated sinoporphyrin sodium-based photodynamic therapy induces autophagic cell death in gastric cancer through regulation of the ROS/PI3K/Akt/mTOR signaling pathway. [Abstract]2022 Dec 8;20(1):475. PMID: 36482460 -
J Headache Pain
Dopamine receptor D2 regulates GLUA1-containing AMPA receptor trafficking and central sensitization through the PI3K signaling pathway in a male rat model of chronic migraine. [Abstract]2022 Aug 10;23(1):98. PMID: 35948867 -
Int J Mol Med
Effects of sesamin on the chemosensitivity, invasiveness and immune evasion mechanism of human lung adenocarcinoma. [Abstract]2025 Nov;56(5):194. PMID: 40937589 -
Int J Mol Med
Dihydroartemisinin inhibits the activation and proliferation of hepatic stellate cells by regulating miR‑29b‑3p. [Abstract]2023 May;51(5):40. PMID: 37026504 -
Int J Mol Med
Rosmarinic acid inhibits cell proliferation, migration, and invasion and induces apoptosis in human glioma cells. [Abstract]2021 May;47(5):67. PMID: 33649774 -
Int J Mol Med
ADAM10 promotes the proliferation of ligamentum flavum cells by activating the PI3K/AKT pathway. [Abstract]2021 Feb;47(2):688-698. PMID: 33416124 -
Mol Med
RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway. [Abstract]2023 Oct 3;29(1):133. PMID: 37789274 -
Arch Pharm Res
Chemerin reverses the malignant phenotype and induces differentiation of human hepatoma SMMC7721 cells. [Abstract]2021 Feb;44(2):194-204. PMID: 33502677 -
Phytother Res
Scutellarein alleviates osteoarthritis progression through the PI3K/Akt/NF-kappaB signaling pathway: In vitro and in vivo studies. [Abstract]2024 Jul;38(7):3509-3524. PMID: 38695125 -
Phytother Res
Silibinin attenuated pseudo-allergic reactions and mast cell degranulation via PLCγ and PI3K/Akt signaling pathway. [Abstract]2023 Aug;37(8):3572-3582. PMID: 37115717 -
Free Radic Biol Med
FKBP5 regulates trophoblast-macrophage crosstalk in recurrent spontaneous abortion through PI3K/AKT and NF-κB signaling pathways. [Abstract]2023 Oct 10;209(Pt 1):55-69. PMID: 37827456 -
-
Cell Rep
CNOT6/6L-mediated mRNA degradation in ovarian granulosa cells is a key mechanism of gonadotropin-triggered follicle development. [Abstract]2021 Nov 16;37(7):110007. PMID: 34788619 -
Cell Prolif
2022 Sep 26;e13342. PMID: 36162830 -
Chin Med
Nitidine chloride induces caspase 3/GSDME-dependent pyroptosis by inhibting PI3K/Akt pathway in lung cancer. [Abstract]2022 Sep 29;17(1):115. PMID: 36175965 -
Int J Oncol
The inhibitory effect of CTAB on human osteosarcoma through the PI3K/AKT signaling pathway. [Abstract]2021 Jul;59(1):42. PMID: 34013357 -
Int J Oncol
Oncogenic role of abnormal spindle‑like microcephaly‑associated protein in lung adenocarcinoma. [Abstract]2021 May;58(5):23. PMID: 33786609 -
J Invest Dermatol
Botulinum neurotoxin type A1 alleviates bleomycin-induced skin fibrosis by inhibiting phosphatidylinositol 3-kinase-protein kinase B (PI3K-Akt) pathway and associated cell cycle and proliferation. [Abstract]2026 Jan 23:S0022-202X(26)00030-8. PMID: 41581589 -
PLoS Biol
Optineurin binding to the novel interacting partner Junction plakoglobin prevents muscle atrophy in mice. [Abstract]2026 Jan 22;24(1):e3003581. PMID: 41570057 -
J Ethnopharmacol
Danggui niantong decoction attenuates synovial fibrosis through regulating PI3k/AKT signaling pathway. [Abstract]2025 Jan 18:119381. PMID: 39832630 -
J Ethnopharmacol
Bie Jia Jian pill ameliorates BDL-induced cholestatic hepatic fibrosis in rats by regulating intestinal microbial composition and TMAO-mediated PI3K/AKT signaling pathway. [Abstract]2025 Jan 30;337(Pt 2):118910. PMID: 39369915 -
J Ethnopharmacol
An ethanolic extract of Arctium lappa L. leaves ameliorates experimental atherosclerosis by modulating lipid metabolism and inflammatory responses through PI3K/Akt and NF-κB singnaling pathways. [Abstract]2024 May 10:325:117768. PMID: 38253275 -
J Ethnopharmacol
Piperine promotes PI3K/AKT/mTOR-mediated gut-brain autophagy to degrade α-Synuclein in Parkinson's disease rats. [Abstract]2024 Mar 25:322:117628. PMID: 38158101 -
J Ethnopharmacol
Compound Danshen Dripping Pill ameliorates post ischemic myocardial inflammation through synergistically regulating MAPK, PI3K/AKT and PPAR signaling pathways. [Abstract]2021 Dec 5:281:114438. PMID: 34390798 -
Biomater Adv
Novel Ce/Cu-modified black ceramics disrupted mitochondrial dysfunction and tricarboxylic acid cycle to induce cuproptosis in osteosarcoma cells. [Abstract]2026 Mar:180:214576. PMID: 41218466 -
J Agric Food Chem
Mechanistic Insights into Maltol-Mediated Reversal of Postmenopausal Osteoporosis via Regulation of CDK14 Ubiquitination in Macrophages. [Abstract]2025 May 2. PMID: 40315161 -
J Agric Food Chem
Ginsenoside Rk1 Prevents UVB Irradiation-Mediated Oxidative Stress, Inflammatory Response, and Collagen Degradation via the PI3K/AKT/NF-κB Pathway In Vitro and In Vivo. [Abstract]2022 Dec 21;70(50):15804-15817. PMID: 36472249 -
Ecotoxicol Environ Saf
Glyphosate promotes calcium oxalate crystal-induced renal injury by modulating the PI3K/Akt-mediated mechanism. [Abstract]2026 Mar 15:313:119962. PMID: 41797104 -
Biochem Pharmacol
ACOD1/Itaconate regulates trophoblast function through the PI3K/Akt/FOLR1 axis to participate in the pathogenesis of recurrent spontaneous abortion. [Abstract]2025 Dec;242(Pt 3):117405. PMID: 41047036 -
Biochem Pharmacol
PX-478 induces apoptosis in acute myeloid leukemia under hypoxia by inhibiting the PI3K/AKT/mTOR pathway through downregulation of GBE1. [Abstract]2024 Nov 9:116620. PMID: 39528073 -
Cell Mol Life Sci
PEBP4 deficiency aggravates LPS-induced acute lung injury and alveolar fluid clearance impairment via modulating PI3K/AKT signaling pathway. [Abstract]2024 Mar 13;81(1):133. PMID: 38472560 -
Cell Biosci
Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE-/- mice. [Abstract]2019 Aug 27;9:68. PMID: 31467666 -
Life Sci
H3K9ac modification was involved in doxorubicin induced apoptosis by regulating Pik3ca transcription in H9C2 cells. [Abstract]2021 Nov 1:284:119107. PMID: 33508292 -
Life Sci
Knockdown of LSD1 meliorates Ox-LDL-stimulated NLRP3 activation and inflammation by promoting autophagy via SESN2-mesiated PI3K/Akt/mTOR signaling pathway. [Abstract]2019 Sep 15:233:116696. PMID: 31351969 -
Bioresour Bioprocess
Unveiling the common mechanisms and therapeutic targets of medicinal herbs in acute pancreatitis: a network pharmacology and experimental validation approach. [Abstract]2025 Jul 30;12(1):82. PMID: 40736877 -
Mol Cell Proteomics
The Hyperproliferation Mechanism of Cholesteatoma Based on Proteomics: SNCA Promotes Autophagy-Mediated Cell Proliferation through the PI3K/AKT/CyclinD1 Signaling Pathway. [Abstract]2023 Sep;22(9):100628. PMID: 37532176 -
Inflammopharmacology
Maltol ameliorates intervertebral disc degeneration through inhibiting PI3K/AKT/NF-κB pathway and regulating NLRP3 inflammasome-mediated pyroptosis. [Abstract]2023 Feb;31(1):369-384. PMID: 36401729 -
Drug Des Devel Ther
Paroxetine as a Therapeutic Agent in Inflammatory Osteolysis: Mechanistic Insights and Efficacy. [Abstract]2026 Jan 27:20:561725. PMID: 41868178 -
-
Cells
Synergism of Feeding and Digestion Regulated by the Neuropeptide F System in Ostrinia furnacalis Larvae. [Abstract]2023 Jan 3;12(1):194. PMID: 36611986 -
Pharm Biol
Deciphering the molecular mechanism of tetrandrine in inhibiting hepatocellular carcinoma and increasing sorafenib sensitivity by combining network pharmacology and experimental evaluation. [Abstract]2022 Dec;60(1):75-86. PMID: 34962429 -
Gene Ther
BRD9 promotes the progression of gallbladder cancer via CST1 upregulation and interaction with FOXP1 through the PI3K/AKT pathway and represents a therapeutic target. [Abstract]2024 Nov;31(11-12):594-606. PMID: 39306629 -
Eur J Pharmacol
Phloretin inhibits osteoclast differentiation and alleviates disuse osteoporosis through the PI3K/AKT/NF-κB pathway. [Abstract]2026 May 28:1025:178925. PMID: 42081991 -
Pharmaceuticals (Basel)
Puerarin Inhibits Proliferation, Migration and Invasion of Colon Cancer Cells and Induces Apoptosis via Suppression of the PI3K/AKT Signaling Pathway. [Abstract]2025 Sep 16;18(9):1378. PMID: 41011246 -
Cell Biol Toxicol
TEAD4-mediated upregulation of LPAR3 augments hepatic stellate cell activation in portal hypertension. [Abstract]2025 Jul 1;41(1):110. PMID: 40591004 -
Eur J Pharmacol
Restoration of ARA metabolic disorders in vascular smooth muscle cells alleviates intimal hyperplasia. [Abstract]2024 Sep 10:176824. PMID: 39265882 -
Eur J Pharmacol
ENAH transcriptionally activated by YY1 promotes growth and invasion of laryngocarcinoma cells through PI3K/AKT signaling. [Abstract]2024 Sep 10:176991. PMID: 39265883 -
Eur J Pharmacol
Tenacissoside H repressed the progression of glioblastoma by inhibiting the PI3K/Akt/mTOR signaling pathway. [Abstract]2024 Apr 5:968:176401. PMID: 38331340 -
Eur J Pharmacol
1,8-Cineole ameliorates endothelial injury and hypertension induced by L-NAME through regulation of autophagy via PI3K/mTOR signaling pathway. [Abstract]2023 Sep 5:954:175863. PMID: 37380045 -
Int Immunopharmacol
Methamphetamine regulates microglial polarization and glycolytic activity to promote Parkinson's disease through the LIPH/LPA/PI3K/AKT signaling axis. [Abstract]2026 Mar 15:173:116306. PMID: 41628513 -
Int Immunopharmacol
Hesperidin ameliorates hepatocyte cell cycle disruption, apoptosis, and necroptosis in mice with nonalcoholic fatty liver disease via the VEGFA-PI3K/AKT pathway. [Abstract]2025 Aug 3:163:115304. PMID: 40759079 -
Int Immunopharmacol
Garcinol promotes wound healing in diabetic mice by regulating inflammation and NLRP3 inflammasome-mediated pyroptosis via the PI3K/Akt/NF-κB pathway. [Abstract]2025 Apr 4:151:114352. PMID: 40022821 -
Int J Mol Sci
Non-Structural Protein V of Canine Distemper Virus Induces Autophagy via PI3K/AKT/mTOR Pathway to Facilitate Viral Replication. [Abstract]2024 Dec 25;26(1):84. PMID: 39795943 -
Noncoding RNA Res
Targeting NUCKS1 with a fragment of tRNAAsn(GUU) of Chinese yew for the treatment of colorectal cancer. [Abstract]2024 Nov 12:11:38-47. PMID: 39736854 -
Int Immunopharmacol
Isorhapontigenin delays senescence and matrix degradation of nucleus pulposus cells via PI3K/AKT/mTOR-mediated autophagy pathway in vitro and alleviates intervertebral disc degeneration in vivo. [Abstract]2024 Jul 26:139:112717. PMID: 39067404 -
Int Immunopharmacol
Moringin alleviates DSS-induced ulcerative colitis in mice by regulating Nrf2/NF-κB pathway and PI3K/AKT/mTOR pathway. [Abstract]2024 May 17:134:112241. PMID: 38761782 -
Int Immunopharmacol
Chondroprotective effects of Apolipoprotein D in knee osteoarthritis mice through the PI3K/AKT/mTOR signaling pathway. [Abstract]2024 May 30:133:112005. PMID: 38626543 -
Int Immunopharmacol
Germacrone mitigates cardiac remodeling by regulating PI3K/AKT-mediated oxidative stress, inflammation, and apoptosis. [Abstract]2023 Sep 5;124(Pt A):110876. PMID: 37683399 -
Int Immunopharmacol
Saikosaponin d modulates the polarization of tumor-associated macrophages by deactivating the PI3K/AKT/mTOR pathway in murine models of pancreatic cancer. [Abstract]2023 Sep:122:110579. PMID: 37433245 -
Int J Mol Sci
Analgesic Effects of Fisetin, Peimine, Astaxanthin, Artemisinin, Bardoxolone Methyl and 740 Y-P and Their Influence on Opioid Analgesia in a Mouse Model of Neuropathic Pain. [Abstract]2023 May 19;24(10):9000. PMID: 37240346 -
Bone Joint Res
Melatonin alleviates senile osteoporosis by regulating autophagy and enhancing fracture healing in aged mice. [Abstract]2025 Feb 6;14(2):97-110. PMID: 39912870 -
Mol Neurobiol
TRPV4 Blockage Inhibits the Neurogenesis in the Adult Hippocampal Dentate Gyrus Following Pilocarpine‑Induced Status Epilepticus. [Abstract]2025 Mar;62(3):3615-3629. PMID: 39312069 -
Glia
EphA4/ephrinA3 reverse signaling mediated downregulation of glutamate transporter GLAST in Müller cells in an experimental glaucoma model. [Abstract]2023 Mar;71(3):720-741. PMID: 36416239 -
Front Pharmacol
Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling. [Abstract]2021 Jul 15:12:667644. PMID: 34335245 -
Front Pharmacol
Eriodictyol Inhibits Proliferation, Metastasis and Induces Apoptosis of Glioma Cells via PI3K/Akt/NF-κB Signaling Pathway. [Abstract]2020 Feb 25;11:114. PMID: 32158391 -
J Integr Med
Astragaloside IV delayed the epithelial-mesenchymal transition in peritoneal fibrosis by inhibiting the activation of EGFR and PI3K-AKT pathways. [Abstract]2025 Sep 4:S2095-4964(25)00137-2. PMID: 40975639 -
J Nutr Biochem
Protective effect of folic acid on MNNG-induced proliferation of esophageal epithelial cells via the PI3K/AKT/mTOR signaling pathway. [Abstract]2024 Jul 16:109702. PMID: 39025456 -
ACS Omega
Silymarin-Functionalized Selenium Nanoparticles Prevent LPS-Induced Inflammatory Response in RAW264.7 Cells through Downregulation of the PI3K/Akt/NF-κB Pathway. [Abstract]2022 Nov 16;7(47):42723-42732. PMID: 36467957 -
J Nutr Biochem
Lipophagy mediated glucose-induced changes of lipid deposition and metabolism via ROS dependent AKT-Beclin1 activation. [Abstract]2022 Feb:100:108882. PMID: 34655756 -
Bioorg Chem
Elucidation of the anti-NSCLC mechanism of flavonoid derivative JW4 by an integrative approach of network pharmacology and experimental verification. [Abstract]2025 Dec 18:169:109400. PMID: 41447948 -
Bioorg Chem
Exploring the mechanism of Levistolide A in the treatment of lung cancer cells based on network analysis, molecular docking and experimental validation. [Abstract]2025 Sep 16:165:109002. PMID: 40974659 -
Mol Med Rep
ABCC9 knockdown attenuates isoproterenol‑induced myocardial hypertrophy by inhibiting the PI3K/AKT signaling pathway. [Abstract]2026 Feb;33(2):60. PMID: 41347799 -
Mol Med Rep
lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway. [Abstract]2021 Jan;23(1):76. PMID: 33236153 -
Stem Cell Rev Rep
ANXA3 activates HIF-1α/VEGF Signaling Via the PI3K/AKT/mTOR Pathway to Promote Osteosarcoma Stem Cell-Like Phenotype. [Abstract]2026 Aug;22(6):2919-2937. PMID: 42313237 -
Sci Rep
Mechanistic study of HES1/PI3K/Akt/mTOR signaling pathway in cisplatin-induced sensorineural hearing loss. [Abstract]2026 Jun 26. PMID: 42350477 -
Mediators Inflamm
FGFR2 is a Candidate Immune-Associated Marker of Diabetic Foot Ulcer That Promotes Keratinocyte Function by Activating the PI3K/Akt and MAPK Pathways. [Abstract]2026;2026(1):e3260549. PMID: 41983566 -
-
Sci Rep
SHP1 and its downstream p38/SP1/PI3K/YAP/Notch-1 signaling in trophoblast cells suppressed the progression of Preeclampsia via inhibiting proliferation of SMCs. [Abstract]2025 May 9;15(1):16205. PMID: 40346122 -
Sci Rep
ITGA5 induces mesenchymal transformation to promote gliomas progression via PI3K/AKT/mTORC1 signaling pathway. [Abstract]2025 Apr 19;15(1):13539. PMID: 40253517 -
Sci Rep
miR-21 regulates autophagy and apoptosis of ectopic endometrial stromal cells of adenomyosis via PI3K/ AKT/ mTOR pathway. [Abstract]2025 Mar 4;15(1):7639. PMID: 40038429 -
Sci Rep
Low intensity pulsed ultrasound alleviates synovial fibrosis in osteoarthritis via the PI3K/AKT pathway. [Abstract]2025 Mar 20;15(1):9644. PMID: 40113833 -
Sci Rep
Genipin promotes the apoptosis and autophagy of neuroblastoma cells by suppressing the PI3K/AKT/mTOR pathway. [Abstract]2024 Aug 30;14(1):20231. PMID: 39215133 -
Sci Rep
Mechanism of apoptosis in oral squamous cell carcinoma promoted by cardamonin through PI3K/AKT signaling pathway. [Abstract]2024 Sep 5;14(1):20802. PMID: 39242879 -
Sci Rep
NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K/AKT signaling. [Abstract]2023 Jul 21;13(1):11795. PMID: 37479837 -
Sci Rep
Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway. [Abstract]2021 Sep 29;11(1):19268. PMID: 34588580 -
Eur J Med Res
DACT1 inhibits cuproptosis and promotes cell malignancy via activation of PI3K/AKT signaling in laryngeal squamous cell carcinoma. [Abstract]2025 Dec 30;31(1):170. PMID: 41469752 -
Cancers (Basel)
ITGA2 Mediates the Resistance of Hepatocellular Carcinoma to Lenvatinib by Activating the AKT/FOXO3A Signaling Pathway. [Abstract]2025 Aug 29;17(17):2846. PMID: 40940943 -
Cancers (Basel)
BI-D1870 Induces Mitotic Dysfunction and Apoptosis in Neuroblastoma by Regulating the PI3K-Akt-mTORC1 Signal Axis. [Abstract]2023 Mar 28;15(7):2023. PMID: 37046682 -
Cell Signal
CLDN6 inhibits breast cancer growth by inducing autophagic cell death through SOX4 m6A modification. [Abstract]2026 Sep:145:112570. PMID: 42070760 -
Cell Signal
ADAR1-mediated destabilization of INPP5J mRNA promotes PI3K/AKT/mTOR signal to inhibit autophagy in lung adenocarcinoma. [Abstract]2026 Sep:145:112616. PMID: 42173180 -
Cell Signal
ANXA1 regulates microglia polarization and autophagy via PI3K/Akt/mTOR pathway to reduce inflammatory injury after cerebral ischemia-reperfusion. [Abstract]2025 Dec 18:139:112336. PMID: 41421718 -
Neuropharmacology
The glutaminase inhibitor JHU-083 mitigates cognitive dysfunction in a mouse model of post-traumatic stress disorder. [Abstract]2025 Nov 15:279:110631. PMID: 40812515 -
Cell Signal
GCN2 promotes fatty acid metabolism through the activation of PI3K/AKT signaling in gastric cancer. [Abstract]2025 Nov:135:111984. PMID: 40651685 -
Cell Signal
Bavachinin alleviates allergic rhinitis by modulating gut microbiota and inhibiting NLRP3-mediated epithelial pyroptosis through PI3K/AKT/NF-κB signaling pathway. [Abstract]2025 Nov:135:112026. PMID: 40738272 -
J Cell Mol Med
Plumbagin ameliorates LPS-induced acute lung injury by regulating PI3K/AKT/mTOR and Keap1-Nrf2/HO-1 signalling pathways. [Abstract]2024 Jul;28(13):e18386. PMID: 38990057 -
Oncol Rep
Synergistic effects of thalidomide and cisplatin are mediated via the PI3K/AKT and JAK1/STAT3 signaling pathways in cervical cancer. [Abstract]2022 Oct;48(4):169. PMID: 35920185 -
Mol Cell Biochem
Involvement of elevated ASF1B in the poor prognosis and tumorigenesis in pancreatic cancer. [Abstract]2022 Jul;477(7):1947-1957. PMID: 35362843 -
J Dairy Sci
β-Hydroxybutyrate impairs the release of bovine neutrophil extracellular traps through inhibiting phosphoinositide 3-kinase-mediated nicotinamide adenine dinucleotide phosphate oxidase reactive oxygen species production. [Abstract]2022 Apr;105(4):3405-3415. PMID: 35123783 -
Mol Cell Biochem
2022 May;477(5):1541-1553. PMID: 35184257 -
Oncol Rep
TMEM100 induces cell death in non‑small cell lung cancer via the activation of autophagy and apoptosis. [Abstract]2021 May;45(5):63. PMID: 34184748 -
Cell Signal
Upregulation of HSP72 attenuates tendon adhesion by regulating fibroblast proliferation and collagen production via blockade of the STAT3 signaling pathway. [Abstract]2020 Jul;71:109606. PMID: 32199935 -
Oncol Rep
Knockdown of SLCO4C1 inhibits cell proliferation and metastasis in endometrial cancer through inactivating the PI3K/Akt signaling pathway. [Abstract]2020 Mar;43(3):919-929. PMID: 32020231 -
J Inflamm Res
Acupuncture Activates PI3K/Akt Pathway to Promote Spinal Microglial M2 Polarization and Alleviate Spastic Hemiplegia Following Ischemic Stroke. [Abstract]2026 Apr 17:19:592917. PMID: 42022268 -
J Inflamm Res
Long Non-Coding RNA lncTAF15:1-1 Promotes CCL5 Secretion and Cell Migration of Monocyte-Derived Dendritic Cells via PI3K/AKT/mTOR Pathway in Systemic Lupus Erythematosus. [Abstract]2025 Aug 3:18:10389-10402. PMID: 40787263 -
Ann N Y Acad Sci
COMMD4 Drives Skin Cutaneous Melanoma Progression by Targeting PI3K-p85 to Activate PI3K-AKT. [Abstract]2025 Nov 24. PMID: 41283898 -
iScience
Ibrutinib-induced pulmonary angiotensin-converting enzyme activation promotes atrial fibrillation in rats. [Abstract]2024 Jan 17;27(2):108926. PMID: 38357670 -
Comp Biochem Physiol C Toxicol Pharmacol
Rosuvastatin calcium and pravastatin sodium regulate the antioxidant system in zebrafish liver through the PI3K/Nrf2/ARE signaling pathway. [Abstract]2026 Jun 4:110596. PMID: 42248540 -
BMC Complement Med Ther
2023 Aug 22;23(1):295. PMID: 37608281 -
Drug Dev Res
The cytotoxicity of karanjin toward breast cancer cells is involved in the PI3K/Akt signaling pathway. [Abstract]2022 Nov;83(7):1673-1682. PMID: 36065628 -
Drug Dev Res
Secoisolariciresinol diglucoside induces pyroptosis by activating caspase-1 to cleave GSDMD in colorectal cancer cells. [Abstract]2022 Aug;83(5):1152-1166. PMID: 35472101 -
Fish Shellfish Immunol
PI3K/AKT/p53 pathway inhibits infectious spleen and kidney necrosis virus infection by regulating autophagy and immune responses. [Abstract]2022 Jan:120:648-657. PMID: 34968710 -
Front Biosci (Landmark Ed)
Splicing Factor PTBP1 Silencing Induces Apoptosis of Human Cervical Cancer Cells via PI3K/AKT Pathway and Autophagy. [Abstract]2024 Aug 19;29(8):289. PMID: 39206910 -
BMC Cancer
GBAP1 functions as a tumor promotor in hepatocellular carcinoma via the PI3K/AKT pathway. [Abstract]2023 Jul 5;23(1):628. PMID: 37407932 -
BMC Cancer
Emodin inhibits invasion and migration of hepatocellular carcinoma cells via regulating autophagy-mediated degradation of snail and β-catenin. [Abstract]2022 Jun 18;22(1):671. PMID: 35715752 -
OncoTargets and Therapy Dovepress
2019 Oct 16;12:8537-8552. PMID: 31802891 -
Naunyn Schmiedebergs Arch Pharmacol
β-defensin-3 promoted osteosarcoma progression via activating the PI3K/AKT pathway and regulated tumor immune response. [Abstract]2026 Jun;399(9):14421-14437. PMID: 41984190 -
Funct Integr Genomics
GCSH promotes colorectal cancer progression by inhibiting Cuproptosis through the PI3K/AKT-FDX1 axis. [Abstract]2026 Jan 27;26(1):32. PMID: 41591502 -
J Cell Physiol
ZNF263 cooperates with ZNF31 to promote the drug resistance and EMT of pancreatic cancer through transactivating RNF126. [Abstract]2024 Jun;239(6):e31259. PMID: 38515383 -
Naunyn Schmiedebergs Arch Pharmacol
Gentiopicroside inhibits retinoblastoma cell proliferation, invasion, and tumorigenesis in nude mice by suppressing the PI3K/AKT pathway. [Abstract]2024 Feb;397(2):1003-1013. PMID: 37555853 -
-
J Hepatocell Carcinoma
CYP2C8 Suppress Proliferation, Migration, Invasion and Sorafenib Resistance of Hepatocellular Carcinoma via PI3K/Akt/p27kip1 Axis. [Abstract]2021 Nov 3;8:1323-1338. PMID: 34765572 -
Viruses
Host DNA Demethylation Induced by DNMT1 Inhibition Up-Regulates Antiviral OASL Protein during Influenza a Virus Infection. [Abstract]2023 Jul 28;15(8):1646. PMID: 37631988 -
J Bioenerg Biomembr
Shionone attenuates endoplasmic reticulum stress-associated ferroptosis in cardiomyocytes by reducing LCN2 and regulating PI3K/Akt signaling. [Abstract]2026 Feb 12;58(1):2. PMID: 41678102 -
Mol Immunol
Isoimperatorin inhibits cell proliferation and induces apoptosis via regulating PI3K/AKT pathway in acute lymphoblastic leukemia. [Abstract]2025 Dec 18:189:181-191. PMID: 41418420 -
Mol Immunol
GDF15 activates the PI3K/AKT pathway to mediate macrophage M2 polarization to promote prostate cancer resistance to docetaxel. [Abstract]2025 Sep:185:27-38. PMID: 40674958 -
Epigenetics
Oncogenic DNA methyltransferase 1 activates the PI3K/AKT/mTOR signalling by blocking the binding of HSPB8 and BAG3 in melanoma. [Abstract]2023 Dec;18(1):2239607. PMID: 37523636 -
Pathol Res Pract
Clinical importance and PI3K/Akt pathway-dependent anti-proliferative role of PALMD and DPT in breast cancer. [Abstract]2023 Sep:249:154717. PMID: 37556876 -
J Pharm Pharmacol
Eleutheroside E functions as anti-cervical cancer drug by inhibiting the phosphatidylinositol 3-kinase pathway and reprogramming the metabolic responses. [Abstract]2022 Sep 1;74(9):1251-1260. PMID: 35789274 -
Toxicol Appl Pharmacol
2026 Jun 26:514:117928. PMID: 42361913 -
J Biochem Mol Toxicol
Silencing of PODXL2 Modulates Cell Viability and Tumor Immune Microenvironment of Prostate Cancer and Involves PI3K/AKT Pathway Inactivation. [Abstract]2025 Apr;39(4):e70210. PMID: 40152216 -
Genomics
SCARA5 in bone marrow stromal cell-derived exosomes inhibits colorectal cancer progression by inactivating the PI3K/Akt pathway. [Abstract]2023 Jul;115(4):110636. PMID: 37150230 -
Toxicol Appl Pharmacol
2022 Apr 15:441:115971. PMID: 35276125 -
Cytokine
Inhibition of macrophage migration inhibitory factor alleviates LPS-induced inflammation response of HEI-OC1 cells via suppressing NF-κB signaling. [Abstract]2022 Feb:150:155776. PMID: 34864396 -
Toxicol Appl Pharmacol
2,5-Hexanedione influences primordial follicular development in cultured neonatal mouse ovaries by interfering with the PI3K signaling pathway via miR-214-3p. [Abstract]2020 Dec 15;409:115335. PMID: 33197454 -
Immun Inflamm Dis
ADAMTS2 Modulates Inflammation, Autophagy, and Barrier Integrity Through PI3K/AKT/mTOR Signaling in LPS-Induced Acute Respiratory Distress Syndrome. [Abstract]2026 Apr;14(4):e70429. PMID: 42011035 -
Appl Biochem Biotechnol
Brucea Javanica Oil Attenuates Osteosarcoma Progression by Reprogramming Tumor-associated Macrophages via Inhibiting PI3K/AKT Pathway. [Abstract]2026 Apr 28. PMID: 42047961 -
Appl Biochem Biotechnol
RNF8 Relieves asthma-induced DNA Damage and Ferroptosis in Airway Epithelial Cells Through the AKT-NRF2 Axis. [Abstract]2026 Mar 13. PMID: 41824268 -
Exp Cell Res
ADAM8 negatively regulates the osteogenic differentiation of rat tendon stem cells through inhibiting the PI3K/AKT signaling pathway. [Abstract]2026 Apr 1;457(1):114924. PMID: 41655939 -
Int J Biochem Cell Biol
EFNA3-mediated autophagy suppression drives breast cancer proliferation, EMT and metastasis via PI3K/AKT/mTOR axis. [Abstract]2026 May:194:106928. PMID: 41763291 -
J Gastroenterol Hepatol
Sanguisorba officinalis L. and Sophora japonica L. Inhibit Angiogenesis in Ulcerative Colitis. [Abstract]2025 Aug;40(8):1991-2006. PMID: 40518692 -
Arch Biochem Biophys
Activation of Sestrin2 accelerates deep second-degree burn wound healing through PI3K/AKT pathway. [Abstract]2023 Jul 15:743:109645. PMID: 37225009 -
Cancer Med
Abnormal downregulation of 10-formyltetrahydrofolate dehydrogenase promotes the progression of oral squamous cell carcinoma by activating PI3K/Akt/Rb pathway. [Abstract]2023 Mar;12(5):5781-5797. PMID: 36336972 -
Exp Cell Res
Rafoxanide promotes apoptosis and autophagy of gastric cancer cells by suppressing PI3K /Akt/mTOR pathway. [Abstract]2019 Dec 15;385(2):111691. PMID: 31678170 -
-
Food Chem Toxicol
CDDO-Me triggers ROS-dependent ferroptosis and apoptosis in cervical cancer via targeting PI3K/Nrf2 pathway. [Abstract]2025 Oct:204:115664. PMID: 40714179 -
Biol Reprod
AQP9 causes recurrent spontaneous abortion by inhibiting trophoblast cell EMT and invasion through the PI3K/AKT pathway. [Abstract]2023 Nov 15;109(5):736-748. PMID: 37602667 -
Mol Biol Rep
Polyene phosphatidylcholine ameliorates synovial inflammation: involvement of PTEN elevation and glycolysis suppression. [Abstract]2023 Jan;50(1):687-696. PMID: 36370296 -
Kaohsiung J Med Sci
Melatonin Exerts Chondroprotective Effects Against Osteoarthritis by Promoting PI3K/AKT/FoxO3-Mediated Mitophagy. [Abstract]2025 Nov 5:e70131. PMID: 41190713 -
J Steroid Biochem Mol Biol
Nano-curcumin attenuates tamoxifen resistance and malignant progression in ER-positive breast cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway. [Abstract]2025 Jul 3:254:106825. PMID: 40617262 -
Oral Dis
2024 Oct;30(7):4231-4242. PMID: 38225738 -
Genes (Basel)
SPAG9 Expression Predicts Good Prognosis in Patients with Clear-Cell Renal Cell Carcinoma: A Bioinformatics Analysis with Experimental Validation. [Abstract]2023 Apr 20;14(4):944. PMID: 37107702 -
Exp Eye Res
Licochalcone A alleviates laser-induced choroidal neovascularization by inhibiting the endothelial-mesenchymal transition via PI3K/AKT signaling pathway. [Abstract]2023 Jan:226:109335. PMID: 36436569 -
Cell Biochem Biophys
Impairing Ferroptosis Through the PI3K/Akt/Nrf2 Pathway: The Way for Nerve Growth Factor to Mitigate Hypoxia-induced Cardiomyocyte Damage. [Abstract]2025 Jun;83(2):2023-2033. PMID: 39549229 -
Cell Biochem Biophys
Sirt4 Overexpression Modulates the JAK2/STAT3 and PI3K/AKT/mTOR Axes to Alleviate Sepsis-Induced Acute Lung Injury. [Abstract]2025 Jun;83(2):1785-1798. PMID: 39400781 -
Neurogastroenterol Motil
Acute stress induces visceral hypersensitivity via glucocorticoid receptor-mediated membrane insertion of TRPM8: Involvement of a non-receptor tyrosine kinase Pyk2. [Abstract]2020 Oct;32(10):1514-1528. PMID: 32391653 -
Theriogenology
RFRP-3 suppresses ovarian granulosa cell function in Tan sheep via dual signaling pathways: PI3K/AKT/mTOR and MAPK/ERK1/2. [Abstract]2026 Aug:260:117909. PMID: 41924772 -
IBRO Neurosci Rep
TNKS1 mediates the PTEN-PI3K/AKT pathway to regulate glycolysis and proliferation in gliomas. [Abstract]2026 Jan 21:20:186-195. PMID: 41660562 -
Hum Cell
AKR1B10 drives hepatic steatosis and inflammation in metabolic dysfunction-associated steatotic liver disease via PI3K/AKT-mediated autophagy suppression. [Abstract]2026 Apr 7;39(4):61. PMID: 41945278 -
Discov Oncol
CDCA5 knockdown potentiates olaparib sensitivity in BRCA1-mutated ovarian cancer through autophagy activation. [Abstract]2025 Sep 30;16(1):1789. PMID: 41026320 -
Curr Microbiol
Paeonol Inhibits the Replication of Bovine Herpesvirus Type 1 In Vitro Through Regulating the PI3K/AKT Pathway. [Abstract]2025 Feb 3;82(3):110. PMID: 39894854 -
PLoS One
Medioresinol from Eucommiae cortex improves myocardial infarction-induced heart failure through activation of the PI3K/AKT/mTOR pathway: A network analysis and experimental study. [Abstract]2024 Sep 27;19(9):e0311143. PMID: 39331625 -
PLoS One
MiR-27a inhibits the growth and metastasis of multiple myeloma through regulating Th17/Treg balance. [Abstract]2024 Oct 16;19(10):e0311419. PMID: 39413115 -
World J Gastrointest Oncol
Deltonin enhances gastric carcinoma cell apoptosis and chemosensitivity to cisplatin via inhibiting PI3K/AKT/mTOR and MAPK signaling. [Abstract]2023 Oct 15;15(10):1739-1755. PMID: 37969408 -
Toxicol In Vitro
Nickel nanoparticles affect the migration and invasion of HTR-8/SVneo cells by downregulating MMP2 through the PI3K/AKT pathway. [Abstract]2022 Apr;80:105328. PMID: 35150872 -
Technol Cancer Res Treat
LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma. [Abstract]2020 Jan-Dec:19:1533033820957023. PMID: 32910747 -
J Mol Histol
ERO1α promotes the proliferation and inhibits apoptosis of colorectal cancer cells by regulating the PI3K/AKT pathway. [Abstract]2023 Dec;54(6):621-631. PMID: 37776473 -
Clin Med Insights Oncol
MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway. [Abstract]2021 May 5:15:11795549211012666. PMID: 34017210 -
Biochem Biophys Res Commun
N6-methyladenosine methyltransferase METTL3 facilitates the aerobic glycolysis of non-small cell lung cancer cells by activating the PI3K/AKT/mTOR pathway. [Abstract]2025 Sep 8:778:152337. PMID: 40706246 -
Biochem Biophys Res Commun
Flavonoid derivative FB-15 inhibits the progression of nasopharyngeal carcinoma by targeting the PI3K-Akt signaling pathway. [Abstract]2025 May 16:771:152037. PMID: 40409114 -
Cancer Rep (Hoboken)
Quercetin Induces Apoptosis Through Downregulating P4HA2 and Inhibiting the PI3K/Akt/mTOR Axis in Hepatocellular Carcinoma Cells: An In Vitro Study. [Abstract]2025 May;8(5):e70220. PMID: 40347062 -
Arch Dermatol Res
Imperatorin promotes melanin degradation in keratinocytes through facilitating autophagy via the PI3K/Akt signaling pathway. [Abstract]2024 Dec 5;317(1):70. PMID: 39636461 -
Biochem Biophys Res Commun
TM6SF1 suppresses the progression of lung adenocarcinoma and M2 macrophage polarization by inactivating the PI3K/AKT/mtor pathway. [Abstract]2024 Jul 23:718:149983. PMID: 38718735 -
Biochem Biophys Res Commun
Gastrodin relieves cognitive impairment by regulating autophagy via PI3K/AKT signaling pathway in vascular dementia. [Abstract]2023 Sep 3:671:246-254. PMID: 37307708 -
J Clin Lab Anal
Silencing of lncRNA MIR31HG promotes nasopharyngeal carcinoma cell proliferation and inhibits apoptosis through suppressing the PI3K/AKT signaling pathway. [Abstract]2022 Dec;36(12):e24720. PMID: 36347827 -
Korean J Physiol Pharmacol
Gaseous signal molecule SO2 regulates autophagy through PI3K/AKT pathway inhibits cardiomyocyte apoptosis and improves myocardial fibrosis in rats with type II diabetes. [Abstract]2022 Nov 1;26(6):541-556. PMID: 36302628 -
Biochem Biophys Res Commun
Chromogranin A-derived peptide CGA47-66 protects against septic brain injury by reducing blood-brain barrier damage through the PI3K/AKT pathway. [Abstract]2022 May 21;605:162-170. PMID: 35339012 -
Onco Targets Ther
Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway. [Abstract]2019 Dec 4;12:10639-10650. PMID: 31824171 -
Int J Gen Med
Fire Acupuncture Combined with Pulse Radiofrequency Relieves Tactile Allodynia in Rats with Postherpetic Neuralgia. [Abstract]2025 Sep 19:18:5699-5716. PMID: 40994884 -
Mol Genet Genomics
WTAP-mediated m6A methylation of CEP55 promotes immune evasion in lung adenocarcinoma by activating the PI3K/AKT/mTOR pathway. [Abstract]2026 Jun 16;301(1):138. PMID: 42298019 -
Cytotechnology
Nuclear receptor subfamily 2 group F member 2 transcriptionally activates 14-3-3 epsilon to promote diffuse large B-cell lymphoma progression. [Abstract]2026 Jun;78(3):96. PMID: 42040327 -
Cytotechnology
Proanthocyanidin B2 alleviates Pg. LPS-induced RAW264.7 cellular inflammation and oxidative stress via PI3K/Akt/NFkB pathway. [Abstract]2025 Apr;77(2):77. PMID: 40078375 -
Exp Ther Med
Ellagic acid inhibits high glucose-induced injury in rat mesangial cells via the PI3K/Akt/FOXO3a signaling pathway. [Abstract]2021 Sep;22(3):1017. PMID: 34373703 -
Oncol Lett
Hematoporphyrin derivative photodynamic therapy induces apoptosis and suppresses the migration of human esophageal squamous cell carcinoma cells by regulating the PI3K/AKT/mTOR signaling pathway. [Abstract]2023 Nov 15;27(1):17. PMID: 38034489 -
Oncol Lett
Targeting transient receptor potential canonical 1 reduces non‑small cell lung cancer chemoresistance and stemness via inhibition of PI3K/AKT signaling. [Abstract]2023 Apr 13;25(6):224. PMID: 37153044 -
Oncol Lett
MicroRNA-23b-3p targets non-SMC condensing I complex subunit G to promote proliferation and inhibit apoptosis of colorectal cancer cells via regulation of the PI3K/AKT signaling pathway. [Abstract]2021 Dec;22(6):812. PMID: 34671426 -
Curr Med Sci
PMEPA1-Mediated Treg Cell Impairment Promotes Endometrial Stromal Invasion via Excessive PI3K/AKT Signaling in Endometriosis. [Abstract]2025 Oct 16. PMID: 41100035 -
Curr Med Sci
Silencing NCAPD3 Inhibits Tumor Growth and Metastasis in Hepatocellular Carcinoma by Suppressing PI3K-AKT Signalling Pathway. [Abstract]2025 Apr;45(2):253-263. PMID: 40029498 -
In Vitro Cell Dev Biol Anim
Calycosin prevents IL-1β-induced articular chondrocyte damage in osteoarthritis through regulating the PI3K/AKT/FoxO1 pathway. [Abstract]2022 Jun;58(6):491-502. PMID: 35705795 -
Ir J Med Sci
PLK4 inhibitor plus bortezomib exhibits a synergistic effect on treating multiple myeloma via inactivating PI3K/AKT signaling. [Abstract]2023 Apr;192(2):561-567. PMID: 35508865 -
Eur J Histochem
Aloe-emodin ameliorates chronic kidney disease fibrosis by inhibiting PI3K-mediated signaling pathway. [Abstract]2025 Jun 17;69(3). PMID: 40832995 -
Braz J Med Biol Res
Low-intensity pulsed ultrasound inhibits chondrocyte senescence by inhibiting PI3K/AKT/mTOR signaling. [Abstract]2025 Mar 24:58:e14408. PMID: 40136230 -
Braz J Med Biol Res
GSK3B inhibition reduced cervical cancer cell proliferation and migration by modulating the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition. [Abstract]2024 Aug 19:57:e13796. PMID: 39166606 -
Respir Physiol Neurobiol
The Cosmc-mediated effects of neutrophil elastase on T antigen expression in BEAS-2B cells. [Abstract]2020 Oct;281:103496. PMID: 32683071 -
Am J Transl Res
Cirsiliol suppresses malignant progression of hepatocellular carcinoma via regulation of glutamine metabolism. [Abstract]2025 Mar 15;17(3):2145-2153. PMID: 40226041 -
Am J Transl Res
Kinesin family member 2A promotes cancer cell viability, mobility, stemness, and chemoresistance to cisplatin by activating the PI3K/AKT/VEGF signaling pathway in non-small cell lung cancer. [Abstract]2021 Apr 15;13(4):2060-2076. PMID: 34017375 -
Curr Eye Res
Kisspeptin Suppresses the Growth of Primary Pterygial Cells via Inhibiting Chemokine (C-X-C Motif) Ligands in Microenvironment. [Abstract]2025 Jun 24:1-9. PMID: 40555256 -
-
Folia Neuropathol
MiR-182 ameliorates neuropathic pain by enhancing the transition from M1 to M2 phenotype polarization via PI3K/AKT signaling. [Abstract]2025;63(3):269-281. PMID: 41229245 -
-
bioRxiv
Efficient Generation of Functional TCRαβ+ Cytotoxic T Cells from hiPSCs via Small-Molecule Modulation. [Abstract]2026 Apr 1:2026.03.31.715684. PMID: 41959015 -
bioRxiv
Epigenome editing of human hematopoietic stem cells enables sustained and reversible thrombosis prevention. [Abstract]2026 Mar 29:2026.03.27.714536. PMID: 41928991 -
-
-
bioRxiv
2025 Mar 26:2025.03.24.645017. PMID: 40196615 -
Biomed Pharmacother
Fraxinellone protects against cardiac injury and decreases ventricular fibrillation susceptibility during myocardial ischemia-reperfusion. [Abstract]2024 Nov:180:117560. PMID: 39442236 -
Heliyon
Mechanisms of Yiai Fuzheng formula in the treatment of triple-negative breast cancer based on UPLC-Q-Orbitrap-HRMS, network pharmacology, and experimental validation. [Abstract]2024 Aug 20;10(17):e36579. PMID: 39319146 -
Heliyon
2024 Jul 10;10(14):e34397. PMID: 39104494 -
Heliyon
Investigating the potential role of α-SNAP in preventing chemotherapy-induced ovarian dysfunction: Insights from cellular and animal models. [Abstract]2024 Jun 10;10(12):e32802. PMID: 38994045 -
Heliyon
Identification of octyl gallate, a novel apoptosis-inducing compound for colon cancer therapy, from Sanguisorba officinalis L. by cell membrane chromatography and UHPLC-(Q)TOF-MS/MS. [Abstract]2024 May 31;10(11):e32230. PMID: 38933948 -
-
-
-
-
bioRxiv
Endothelial Cell SMAD6 Balances ACVRL1/Alk1 Function to Regulate Adherens Junctions and Hepatic Vascular Development. [Abstract]2023 Mar 25:2023.03.23.534007. PMID: 36993438 -
Contrast Media Mol Imaging
Effects of circFOXO3 on the Proliferation and Invasion of Liver Cancer Cells by Regulating PI3K/Akt Pathway. [Abstract]2022 Jul 14:2022:2109908. PMID: 35909586 -
Bioengineered
Cleavage stimulation factor 2 promotes malignant progression of liver hepatocellular carcinoma by activating phosphatidylinositol 3'-kinase/protein kinase B/mammalian target of rapamycin pathway. [Abstract]2022 Apr;13(4):10047-10060. PMID: 35412944 -
-
Bioengineered
Uncovering the action mechanism of homoharringtonine against colorectal cancer by using network pharmacology and experimental evaluation. [Abstract]2021 Dec;12(2):12940-12953. PMID: 34847838 -
Aging (Albany NY)
Melatonin inhibits proliferation, migration, and invasion by inducing ROS-mediated apoptosis via suppression of the PI3K/Akt/mTOR signaling pathway in gallbladder cancer cells. [Abstract]2021 Sep 27;13(18):22502-22515. PMID: 34580235 -
Dis Markers
Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway. [Abstract]2021 Sep 1:2021:9950663. PMID: 34512817 -
Oxid Med Cell Longev
Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS-PI3K/AKT Signaling and Attenuated Osteolysis. [Abstract]2021 Mar 30:2021:6661534. PMID: 33859780 -
Biomed Pharmacother
Fetuin B overexpression suppresses proliferation, migration, and invasion in prostate cancer by inhibiting the PI3K/AKT signaling pathway. [Abstract]2020 Nov;131:110689. PMID: 32892030
Pureté et documentation
Références
[1]. Derossi D, et al. Stimulation of mitogenesis by a cell-permeable PI 3-kinase binding peptide. [Content Brief]
[2]. Xiaoli Feng, et al. Graphene Oxide Induces p62/SQSTM-dependent Apoptosis Through the Impairment of Autophagic Flux and Lysosomal Dysfunction in PC12 Cells. Acta Biomater. 2018 Nov;81:278-292. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)